| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.06 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.097 | 0.06 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.07 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |